We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The European Medicines Agency (EMEA) Dec. 6 launched an online database aimed at improving consumer access to information about all human and veterinary medicines available in the European Union (EU).
Patients implanted with drug-eluting stents who have not had cardiovascular events or additional procedures within six months of follow-up may benefit from extended use of sanofi-aventis’ blood-thinning drug Plavix, according to a study being published in the Jan. 10 issue of The Journal of the American Medical Association.
Patients implanted with drug-eluting stents who have not had cardiovascular events or additional procedures within six months of follow-up may benefit from extended use of sanofi-aventis’ blood-thinning drug Plavix, according to a study being published in the Jan. 10 issue of The Journal of the American Medical Association (JAMA). Read More
Antidepressant use appears to raise the risk of suicidal thoughts and behavior for adults aged 18–30, but may lower it in adults over 30, according to an FDA staff briefing document. Read More
The use of high doses of epoetin to treat anemia in patients with chronic kidney disease raises the risk for cardiovascular events, results from a new study caution. Read More
Painkiller Aleve may slightly increase the risk of heart attacks and strokes, a new study says, but researchers warn the results are not conclusive. Read More
In the latest round of scrutinizing sanofi-aventis’ antibiotic Ketek, the FDA is holding a joint advisory meeting to address potential health risks associated with the drug. Read More
In its first major announcement since the midterm elections gave control of the next Congress to the Democrats, the FDA outlined what it believes should be the priorities to improve drug safety without sacrificing innovation.
The World Health Organization (WHO) is set to unveil a sweeping plan to wipe out international trafficking in illegal drugs at a Nov. 15 meeting in Bonn, Germany.